What is the ExoDx™ Prostate Test? The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the "gray zone", considering an initial biopsy. The ExoDx Prostate test returns a risk score that determines a patient's risk of clinically significant prostate cancer Our review showed that the PSA test seems to have a high sensitivity but a relatively low specificity. PSA with a cutoff in the range of 2 to 2.99 ng/mL showed a higher sensitivity, specificity, and area under the HSROC compared with cutoffs of from 3 to 3.99 ng/mL and >4 ng/mL. Advising well men about the PSA test for prostate cancer PSA is specific for the prostate, but not for prostate cancer. Multiple factors influence PSA value. Determination of PSA levels is not 100% sensitive for prostate cancer, as PSA levels may be normal despite presence of prostate cancer. The cutoff value for PSA of 4.0 ng/mL gives the highest sensitivity and highest specificity. Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths. Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians. the sensitivity of DRE for prostate cancer was 16.7%. The It is highly specific for prostate glandular cells and thus used in the differentiation of metastatic prostate cancers from other tumor types. SLC45A3 may be expressed in PSA-negative prostate tumors, and the use of these markers in conjunction offers increased sensitivity in the identification of prostate cancer metastases 7. Weaker expression Bumps or growths can indicate the presence of prostate cancer. Along with a PSA test, a doctor can help confirm a prostate cancer diagnosis by feeling for growths or tumors through the rectum A PSA level >4.0 micrograms/L has a sensitivity of 21% and specificity of 91% for a cancer being detected on a subsequent prostate biopsy. and benefits of both a PSA test and DRE should be part of an informed discussion and that if the decision to test for prostate cancer is made, DRE be NjZ8n.

sensitivity of psa test for prostate cancer